Camilo Jimenez, M.D.
Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine
About Dr. Jimenez
Dr. Jimenez is a Professor of Endocrine Neoplasia and Hormonal Disorders at the University of Texas MD Anderson Cancer Center. He is the principal investigator of six clinical trials for patients with metastatic pheochromocytomas and paragangliomas. His research led to the identification of high specific activity MIBG as an effective medication for metastatic pheochromocytomas and paragangliomas and that this medication became the first FDA approved medication in the United States for this indication. Dr. Jimenez has performed extensive clinical research in the field of endocrine cancer with a particular interest in pheochromocytomas and paragangliomas. Dr. Jimenez was one of the first clinicians to describe the use of tyrosine kinase inhibitors in patients affected with sporadic and hereditary (Von Hippel-Lindau and Paraganglioma syndrome type 4) metastatic pheochromocytomas and sympathetic paragangliomas. His observations led to the development of prospective multi-institutional, international clinical trials including a promising phase 2 clinical trial with Cabozantinib. Dr. Jimenez is also the principal investigator of two clinical trials with immunotherapy for metastatic pheochromocytoma and paraganglioma. Dr. Jimenez also characterized inherent complications related to excessive hormonal secretion and tumor burden distinctive of this disease. His seminal accomplishments include assessing the value of antiresortive agents and chemotherapy against bone metastases; demonstrating that systemic chemotherapy with cyclophosphamide, vincristine, and dacarbazine is associated with an improved overall survival; describing the clinical predictors of aggressiveness and overall survival of these tumors, the value of surgery in patients with metastatic disease, and the managing of gastrointestinal and cardiovascular complications. Dr. Jimenez has published more than 130 manuscripts in high impact journals and chapters for prestigious books, including Harrison’s Principles of Internal Medicine and Thyroid. He was member of the editorial board for the Journal of Clinical Endocrinology and Metabolism and he is member of the editorial board of the journals Cancers and Frontiers in Endocrinology. Dr. Jimenez presented at the Schimke Memorial Lecture Grand Rounds at the University of Kansas and has been invited to give lectures for Grand Rounds at several other institutions. He is the principal investigator and collaborator for several clinical and laboratory research studies. Additionally, Dr. Jimenez has lectured in many national and international scientific meetings and he was the co-chair of the International Society for Pheochromocytoma and Paraganglioma Research PRESSOR. He was recognized by the PheoPara Alliance because of his contributions to the field with the 2015 science award. Dr. Jimenez was also the Chair of the Diversity and Membership Committee of the North American Neuroendocrine Tumor Society NANETS. His very focused and successful career has positioned him as an example to be followed by the new generations of endocrinologists. Emblematic of this success, the Endocrine Society invited him, two years in succession, to give the honorary lecture titled “How I got here? A personal journey.”
Read More
Present Title & Affiliation
Primary Appointment
Professor, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Chair, International Society for Pheochromocytoma and Paraganglioma Research Support PRESSOR, Houston, TX
Chair, Diversity Inclusion and Equity Membership Committee of North American Neuroendocrine Tumor Society, Houston, TX
Medical Advisor Board Member, Pheo Para Alliance, Houston, TX
Associate Professor, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Chair, North American Neuroendocrine Tumor Society Guidelines Panel for Metastatic Pheochromocytoma and Paraganglioma, Houston, TX
Chair of the Pheochromocytoma Paraganglioma TNM Staging Group, American Joint Commission for Cancer, Houston, TX
Panel Member, American Association of Endocrine Surgeons Guidelines on Adrenal Tumors, Houston, TX
Dual/Joint/Adjunct Appointment
Adjunct Professor, The William J. Harrington Medical Training Program of Latin America, The University of Miami, Jackson Memorial Hospital, Miami, FL
Research Interests
Pheochromocytomas, Paragangliomas, Multiple Endocrine Neoplasias, Medullary Thyroid Cancer, Endocrine Sequelae of Cancer Therapies
Clinical Interests
Pheochromocytomas, Paragangliomas, Multiple Endocrine Neoplasias, Medullary Thyroid Cancer, Endocrine Sequelae of Cancer Therapies For general clinic information and referrals, please visit the Department of Endocrine Neoplasia and Hormonal Disorders' contact information webpage at: Contact Information
Education & Training
Degree-Granting Education
| 1995 | Pontificia Universidad Javeriana, Santafe de Bogota, COL, MD, Medicine and Surgery |
Postgraduate Training
| 2001-2004 | Clinical Fellowship, Endocrinology, Diabetes and Metabolism, Baylor College of Medicine and The University of Texas MD Anderson Cancer Center, Houston, TX |
| 1999-2001 | Clinical Residency, Internal Medicine, The University of Miami Jackson Memorial Hospital, Miami, FL |
| 1998-1999 | Clinical Internship, Internal Medicine, The University of Miami Jackson Memorial Hospital, Miami, FL |
| 1996-1998 | Clinical Residency, Internal Medicine, The National Cancer Institute, Santa fe de Bogota |
Board Certifications
| 2007 | Endocrinology, Diabetes and Metabolism |
| 2002 | American Board of Internal Medicine |
Experience & Service
Academic Appointments
Assistant Professor, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2012
Assistant Professor, The National Cancer Institute, Bogota, 2004 - 2006
Administrative Appointments/Responsibilities
Representative, Department of Faculty Committee on Diversity, Equality, and Inclusion, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - 2023
Institutional Committee Activities
Diversity Leader, Faculty Diversity, Equity and Inclusion, 2021 - 2023
Consultantships
Member of the Medical Advisory Board, Lantheus, Houston, TX, 2021 - Present
Member of the Medical Advisory Board, Merck, Houston, TX, 2020 - Present
Member of the Medical Advisory Board, HRA Pharma, Houston, TX, 2020 - Present
Honors & Awards
| 2020 | Endocrine Reviews Thyroid Disease Thematic Issue, Endocrine Society |
| 2020 | Top 1% Provider in Patient Experience, Press Ganey |
| 2020 | Top 1% Performer, Consumer Assessment of Healthcare Providers and Systems |
| 2019 | Wall of Science, University of Texas MD Anderson Cancer Center |
| 2019 | Best Doctors in America®, The Best Doctors in America® |
| 2019 | Pituitary, Gonad, Adrenal and Neuroendocrine Disease State Network Committee Member, AACE |
| 2019 | Top 1% Performer, Consumer Assessment of Healthcare Providers and Systems |
| 2018 | Nomination for the 2018 Division Faculty Excellence Award in Research |
| 2018 | Top 1% Performer, Consumer Assessment of Healthcare Providers and Systems |
Selected Publications
Peer-Reviewed Articles
- Yip L, Duh QY, Wachtel H, Jimenez C, Sturgeon C, Lee C, Velázquez-Fernández D, Berber E, Hammer GD, Bancos I, Lee JA, Marko J, Morris-Wiseman LF, Hughes MS, Livhits MJ, Han MA, Smith PW, Wilhelm S, Asa SL, Fahey TJ, McKenzie TJ, Strong VE, Perrier ND. American Association of Endocrine Surgeons Guidelines for Adrenalectomy: Executive Summary. JAMA Surg. e-Pub 2022. PMID: 35976622.
- Wu J, Lakomy DS, Fellman BM, Salcedo MP, Sood AK, Jhingran A, Klopp AH, Iyer RB, Jimenez C, Colbert LE, Eifel PJ, Schmeler KM, Lin LL. Longitudinal Changes in Bone Mineral Measurements Inside and Outside Radiation Fields Used for Cervical Cancer Treatment. Pract Radiat Oncol. e-Pub 2022. PMID: 35390531.
- Srougi V, Bancos I, Daher M, Lee JE, Graham PH, Karam JA, Henriquez A, Mckenzie TJ, Sada A, Bourdeau I, Poirier J, Vaidya A, Abbondanza T, Kiernan CM, Rao SN, Hamidi O, Sachithanandan N, Hoff AO, Chambo JL, Almeida MQ, Habra MA, Fragoso MCBV. Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival. J Clin Endocrinol Metab 107(4):964-971, 2022. PMID: 34850915.
- Daher M, Varghese J, Gruschkus SK, Jimenez C, Waguespack SG, Bedrose S, Altameemi L, Bazerbashi H, Naing A, Subaiah V, Campbell MT, Shah AY, Zhang M, Sheth RA, Karam JA, Wood CG, Perrier ND, Graham PH, Lee JE, Habra MA. Temporal Trends in Outcomes in Patients with Adrenocortical Carcinoma: A Multidisciplinary Referral Center Experience. J Clin Endocrinol Metab. e-Pub 2022. PMID: 35092681.
- Jimenez C, Xu G, Varghese J, Graham PH, Campbell MT, Lu Y. New Directions in Treatment of Metastatic or Advanced Pheochromocytomas and Sympathetic Paragangliomas: an American, Contemporary, Pragmatic Approach. Current Oncology Reports, 2022.
- Jimenez C, Armaiz-Pena G, Dahia PLM, Lu Y, Toledo RA, Varghese J, Habra MA. Endocrine and Neuroendocrine Tumors Special Issue-Checkpoint Inhibitors for Adrenocortical Carcinoma and Metastatic Pheochromocytoma and Paraganglioma: Do They Work?. Cancers (Basel) 14(3), 2022. e-Pub 2022. PMID: 35158739.
- Fishbein L, Del Rivero J, Else T, Howe JR, Asa SL, Cohen DL, Dahia PLM, Fraker DL, Goodman KA, Hope TA, Kunz PL, Perez K, Perrier ND, Pryma DA, Ryder M, Sasson AR, Soulen MC, Jimenez C. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma. Pancreas 50(4):469-493, 2021. PMID: 33939658.
- Liu Z, Jimenez C, Wood C, Zhang M. A Case of Juxtaglomerular Cell Tumor with an Unusual Clinical Presentation. Human Pathology: Case Reports 22, 2020.
- Armaiz-Pena G, Flores SK, Cheng ZM, Zhang X, Esquivel E, Poullard N, Vaidyanathan A, Liu Q, Michalek J, Santillan-Gomez AA, Liss M, Ahmadi S, Katselnik D, Maldonado E, Agosto Salgado S, Jimenez C, Fishbein L, Hamidi O, Else T, Lechan R, Tischler A, Benn DE, Dwight T, Clifton-Bligh R, Sanso G, Barontini M, Vincent D, Aronin N, Biondi B, Koops M, Bowhay-Carnes E, Gimenez-Roqueplo AP, Alvarez-Eslava A, Bruder JM, Kitano M, Burnichon N, Ding Y, Dahia PLM. Genotype-phenotype features of germline variants of the TMEM127 pheochromocytoma susceptibility gene: a ten-year update. J Clin Endocrinol Metab. e-Pub 2020. PMID: 33051659.
- Dahia PLM, Clifton-Bligh R, Gimenez-Roqueplo AP, Robledo M, Jimenez C. Metastatic pheochromocytoma and paraganglioma: proceedings of the MEN2019 workshop. Endocr Relat Cancer 27(8):T41-T52, 2020. e-Pub 2020. PMID: 32069214.
- Jimenez C, Subbiah V, Stephen B, Ma J, Milton D, Xu M, Zarifa A, Akhmedzhanov FO, Tsimberidou A, Habra MA, Rodon Anhert J, Fu S, Naing A. Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas. Cancers (Basel) 12(8), 2020. e-Pub 2020. PMID: 32824391.
- Jimenez C, Fazeli S, Román-Gonzalez A. Antiangiogenic therapies for pheochromocytoma and paraganglioma. Endocr Relat Cancer 27(7):R239-R254, 2020. e-Pub 2020. PMID: 32369773.
- Lopez-Montoya V, Gutierrez-Restrepo J, Grajales JLT, Aristizabal N, Pantoja D, Roman-Gonzalez A, Jimenez C. Ectopic Cushing syndrome in Colombia. Arch Endocrinol Metab. e-Pub 2020. PMID: 32609152.
- Jimenez C, Núñez R, Wendt R. High-specific-activity iodine 131 metaiodobenzylguanidine for the treatment of metastatic pheochromocytoma or paraganglioma: a novel therapy for an orphan disease. Curr Opin Endocrinol Diabetes Obes. e-Pub 2020. PMID: 32250976.
- Jozaghi Y, Zafereo ME, Perrier ND, Wang JR, Grubbs E, Gross ND, Fisher S, Sturgis EM, Goepfert RP, Lai SY, Best C, Busaidy NL, Cabanillas ME, Dadu R, Gagel RF, Habra MA, Hu MI, Jimenez C, Sherman SI, Thosani S, Varghese J, Waguespack SG, Weitzman S, Ying AK, Graham PH. Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines. Head Neck. e-Pub 2020. PMID: 32437031.
- Salcedo MP, Sood AK, Jhingran A, Eifel PJ, Klopp AH, Iyer RB, Felllman BM, Jimenez C, Schmeler KM. Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: A prospective study of 239 women. Cancer. e-Pub 2020. PMID: 32125711.
- Naing A, Meric-Bernstam F, Stephen B, Karp DD, Hajjar J, Rodon Ahnert J, Piha-Paul SA, Colen RR, Jimenez C, Raghav KP, Ferrarotto R, Tu SM, Campbell M, Wang L, Sabir SH, Tapia C, Bernatchez C, Frumovitz M, Tannir N, Ravi V, Khan S, Painter JM, Abonofal A, Gong J, Alshawa A, McQuinn LM, Xu M, Ahmed S, Subbiah V, Hong DS, Pant S, Yap TA, Tsimberidou AM, Dumbrava EEI, Janku F, Fu S, Simon RM, Hess KR, Varadhachary GR, Amir Habra M. Phase 2 study of pembrolizumab in patients with advanced rare cancers. J Immunother Cancer 8(1), 2020. PMID: 32188704.
- Kroiss M, Megerle F, Kurlbaum M, Zimmermann S, Wendler J, Jimenez C, Lapa C, Quinkler M, Scherf-Clavel O, Habra MA, Fassnacht M. Objective response and prolonged disease control of advanced adrenocortical carcinoma with cabozantinib. J Clin Endocrinol Metab. e-Pub 2020. PMID: 31900481.
- Tritos NA, Mattsson AF, Vila G, Biller B, Klibanski A, Valluri SR, Hey-Hadavi J, Kelepouris N, Jimenez C. ALL-CAUSE MORTALITY IN PATIENTS WITH ACROMEGALY TREATED WITH PEGVISOMANT AN ACROSTUDY ANALYSIS. Eur J Endocrinol. e-Pub 2020. PMID: 31917681.
- Economides MP, Shah AY, Jimenez C, Habra MA, Desai M, Campbell MT. A Durable Response With the Combination of Nivolumab and Cabozantinib in a Patient With Metastatic Paraganglioma: A Case Report and Review of the Current Literature. Front Endocrinol (Lausanne) 11:594264, 2020. e-Pub 2020. PMID: 33329398.
- Jasim S, Jimenez C. Metastatic pheochromocytoma and paraganglioma: Management of endocrine manifestations, surgery and ablative procedures, and systemic therapies. Best Pract Res Clin Endocrinol Metab:101354. e-Pub 2019. PMID: 31685417.
- Habra MA, Stephen B, Campbell M, Hess K, Tapia C, Xu M, Rodon Ahnert J, Jimenez C, Lee JE, Perrier ND, Boraddus RR, Pant S, Subbiah V, Hong DS, Zarifa A, Fu S, Karp DD, Meric-Bernstam F, Naing A. Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma. J Immunother Cancer 7(1):253, 2019. e-Pub 2019. PMID: 31533818.
- Kutahyalioglu M, Nguyen HT, Kwatampora L, Clarke C, Silva A, Ibrahim E, Waguespack SG, Cabanillas ME, Jimenez C, Hu MI, Sherman SI, Kopetz S, Broaddus R, Dadu R, Wanland K, Williams M, Zafereo M, Perrier N, Busaidy NL. Genetic profiling as a clinical tool in advanced parathyroid carcinoma. J Cancer Res Clin Oncol. e-Pub 2019. PMID: 31309300.
- Cabanillas ME, Ryder M, Jimenez C. Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond. Endocr Rev. e-Pub 2019. PMID: 31322645.
- Jimenez C, Erwin W, Chasen B. Targeted Radionuclide Therapy for Patients with Metastatic Pheochromocytoma and Paraganglioma: From Low-Specific-Activity to High-Specific-Activity Iodine-131 Metaiodobenzylguanidine. Cancers (Basel) 11(7), 2019. e-Pub 2019. PMID: 31330766.
- Habra MA, Sukkari MA, Hasan A, Albousen Y, Elsheshtawi MA, Jimenez C, Campbell M, Karam JA, Graham PH, Hatia RI, Phan AT, Varghese J, Hassan MM. Epidemiological Risk Factors for Adrenocortical Carcinoma: A Hospital-based Case-Control Study. Int J Cancer. e-Pub 2019. PMID: 31241762.
- Pryma DA, Chin BB, Noto RB, Dillon JS, Perkins S, Solnes L, Kostakoglu L, Serafini AN, Pampaloni MH, Jensen J, Armor T, Lin T, White T, Stambler N, Apfel S, DiPippo V, Mahmood S, Wong V, Jimenez C. Efficacy and Safety of High-Specific-Activity I-131 MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma. J Nucl Med. e-Pub 2018. PMID: 30291194.
- Roman-Gonzalez A, Zhou S, Ayala-Ramirez M, Shen C, Waguespack SG, Habra MA, Karam JA, Perrier N, Wood CG, Jimenez C. Impact of Surgical Resection of the Primary Tumor on Overall Survival in Patients With Metastatic Pheochromocytoma or Sympathetic Paraganglioma. Ann Surg 268(1):172-178, 2018. e-Pub 2017. PMID: 28257320.
- Sagiv O, Kandl TJ, Thakar SD, Thuro BA, Busaidy NL, Cabanillas M, Jimenez C, Dadu R, Graham PH, Debnam JM, Esmaeli B. Extraocular Muscle Enlargement and Thyroid Eye Disease-like Orbital Inflammation Associated with Immune Checkpoint Inhibitor Therapy in Cancer Patients. Ophthalmic Plast Reconstr Surg. e-Pub 2018. PMID: 29927883.
- Romero Arenas MA, Rich TA, Hyde SM, Busaidy NL, Cote GJ, Hu MI, Gagel RF, Gidley PW, Jimenez C, Kupferman ME, Peterson SK, Sherman SI, Ying A, Bassett RL, Waguespack SG, Perrier ND, Grubbs EG. Recontacting Patients With Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma. Ann Surg Oncol 25(5):1395-1402, 2018. e-Pub 2018. PMID: 29427212.
- Jimenez C, Ayala-Ramirez M, Liu J, Nunez R, Gagel RF. Inhibition of Growth Hormone Receptor Activation by Pegvisomant may Increase Bone Density in Acromegaly. Horm Metab Res 43(1):55-61, 2018. e-Pub 2010. PMID: 21104581.
- Toledo R, Jimenez C. Recent advances in the management of malignant pheochromocytoma and paraganglioma: focus on tyrosine kinase and hypoxia-inducible factor inhibitors. F1000Res 7, 2018. e-Pub 2018. PMID: 30109021.
- Jimenez P, Tatsui C, Jessop A, Thosani S, Jimenez C. Treatment for Malignant Pheochromocytomas and Paragangliomas: 5 Years of Progress. Curr Oncol Rep 19(12):83, 2017. e-Pub 2017. PMID: 29081018.
- Noreña JA, Niño CD, Gallego S, Builes-Barrera CA, Castro DC, Román-González A, Jimenez C. Calcitriol-mediated hypercalcemia secondary to granulomatous disease caused by soft-tissue filler injection: a case report. Clin Cases Miner Bone Metab 14(3):340-346, 2017. e-Pub 2017. PMID: 29354165.
- Jasim S, Suman VJ, Jimenez C, Harris P, Sideras K, Burton JK, Worden FP, Auchus RJ, Bible KC. Phase II trial of Pazopanib in Advanced/Progressive Malignant Pheochromocytoma and Paraganglioma. Endocrine 57(2):220-225, 2017. e-Pub 2017. PMID: 28685225.
- Roman-Gonzalez A, Jimenez C. Malignant Pheochromocytoma-Paraganglioma: Pathogenesis, TNM Staging, and Current Clinical Trials. Curr Opin Endocrinol Diabetes Obes 24(3):174-183, 2017. e-Pub 2017. PMID: 28234804.
- Tritos NA, Chanson P, Jimenez C, King D, Jönsson PJ, Klibanski A, Biller BM. Effectiveness of First-Line Pegvisomant Monotherapy in Acromegaly: An ACROSTUDY Analysis. Eur J Endocrinol 176(2):213-220, 2017. e-Pub 2016. PMID: 27932529.
- Xu JY, Grubbs EG, Waguespack SG, Jimenez C, Gagel RF, Sosa JA, Sellin RV, Dadu R, Hu MI, Trotter CS, Jackson M, Rich TA, Hyde SM, Sherman SI, Cote GJ. Medullary Thyroid Carcinoma Associated with Germline RET K666N Mutation. Thyroid 26(12):1744-1751, 2016. e-Pub 2016. PMID: 27673361.
- Xu JY, Murphy WA, Milton DR, Jimenez C, Rao SN, Habra MA, Waguespack SG, Dadu R, Gagel RF, Ying AK, Cabanillas ME, Weitzman SP, Busaidy NL, Sellin RV, Grubbs E, Sherman SI, Hu MI. Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma. J Clin Endocrinol Metab 101(12):4871-4877, 2016. e-Pub 2016. PMID: 27662441.
- Xu JY, Handy B, Michaelis CL, Waguespack SG, Hu MI, Busaidy N, Jimenez C, Cabanillas ME, Fritsche HA, Cote GJ, Sherman SI. Detection and Prognostic Significance of Circulating Tumor Cells in Patients with Metastatic Thyroid Cancer. J Clin Endocrinol Metab:jc20162567. e-Pub 2016. PMID: 27575943.
- Waingankar N, Bratslavsky G, Jimenez C, Russo P, Kutikov A. Pheochromocytoma in Urologic Practice. Eur Urol Focus 1(3):231-240, 2016. e-Pub 2016. PMID: 28078330.
- Gao J, He Q, Subudhi S, Aparicio A, Zurita-Saavedra A, Lee DH, Jimenez C, Suarez-Almazor M, Sharma P. Review of Immune-Related Adverse Events in Prostate Cancer Patients Treated with Ipilimumab: MD Anderson Experience. Oncogene 34(43):5411-7, 2015. e-Pub 2015. PMID: 25659583.
- Phan LM, Fuentes-Mattei E, Wu W, Velazquez-Torres G, Sircar K, Wood CG, Hai T, Jimenez C, Cote GJ, Ozsari L, Hofmann MC, Zheng S, Verhaak R, Pagliaro L, Cortez MA, Lee MH, Yeung SC, Habra MA. Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma. Cancer Res 75(19):4131-42, 2015. e-Pub 2015. PMID: 26282167.
- Rich T, Jackson M, Roman-Gonzalez A, Shah K, Cote GJ, Jimenez C. Metastatic Sympathetic Paraganglioma in a Patient With Loss of the SDHC Gene. Fam Cancer. e-Pub 2015. PMID: 26162468.
- Ozsari L, Kutahyalioglu M, Elsayes KM, Vicens RA, Sircar K, Jazaerly T, Waguespack SG, Busaidy NL, Cabanillas ME, Dadu R, Hu MI, Vassilopoulou-Sellin R, Jimenez C, Lee JE, Habra MA. Preexisting Adrenal Masses in Patients With Adrenocortical Carcinoma: Clinical and Radiological Factors Contributing to Delayed Diagnosis. Endocrine. e-Pub 2015. PMID: 26206754.
- Martucci VL, Emaminia A, Del Rivero J, Lechan RM, Magoon BT, Galia A, Fojo T, Leung S, Lorusso R, Jimenez C, Shulkin BL, Audibert JL, Adams KT, Rosing DR, Vaidya A, Dluhy RG, Horvath KA, Pacak K. Succinate Dehydrogenase Gene Mutations in Cardiac Paragangliomas. Am J Cardiol 115(12):1753-9, 2015. e-Pub 2015. PMID: 25896150.
- Thosani S, Ayala-Ramirez M, Roman-Gonzalez A, Zhou S, Thosani N, Bisanz A, Jimenez C. Constipation: An Overlooked, Unmanaged Symptom of Patients with Pheochromocytoma and Sympathetic Paraganglioma. Eur J Endocrinol. e-Pub 2015. PMID: 26060051.
- Dadu R, Shah K, Busaidy NL, Waguespack SG, Habra MA, Ying AK, Hu MI, Bassett R, Jimenez C, Sherman SI, Cabanillas ME. Efficacy and Tolerability of Vemurafenib in Patients with BRAFV600E - Positive Papillary Thyroid Cancer: MD Anderson Cancer Center Off Label Experience. J Clin Endocrinol Metab 100(1):E77-81, 2015. PMID: 25353071.
- Rich TA, Feng L, Busaidy N, Cote GJ, Gagel RF, Hu M, Jimenez C, Lee JE, Perrier N, Sherman SI, Waguespack SG, Ying A, Grubbs E. Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations. Thyroid 24(7):1096-106, 2014. e-Pub 2014. PMID: 24617864.
- Hu MI, Ying AK, Jimenez C. Update on medullary thyroid cancer. Endocrinol Metab Clin North Am 43(2):423-42, 2014. PMID: 24891170.
- Dadu R, Waguespack SG, Sherman SI, Hu MI, Busaidy NL, Jimenez C, Habra MA, Ying AK, Bassett RL, Cabanillas ME. Efficacy and tolerability of different starting doses of sorafenib in patients with differentiated thyroid cancer. Oncologist 19(5):477-82, 2014. e-Pub 2014. PMID: 24733667.
- Shawa H, Elsayes KM, Javadi S, Morani A, Williams MD, Lee JE, Waguespack SG, Busaidy NL, Vassilopoulou-Sellin R, Jimenez C, Habra MA. Adrenal Ganglioneuroma: Features and Outcomes of 27 Cases at a Referral Cancer Centre. Clin Endocrinol (Oxf) 80(3):342-7, 2014. e-Pub 2013. PMID: 24033606.
- Shawa H, Elsayes KM, Javadi S, Sircar K, Jimenez C, Habra MA. Clinical and Radiological Features of Pheochromocytoma/Ganglioneuroma Composite Tumors: A Case Series with Comparative Analysis. Endocr Pract:1-19. e-Pub 2014. PMID: 24641930.
- Cabanillas ME, Hu MI, Jimenez C. Medullary Thyroid Cancer in the Era of Tyrosine Kinase Inhibitors: To Treat or Not to Treat-And with Which Drug-Those Are the Questions. J Clin Endocrinol Metab, 2014. PMID: 25238206.
- Cabanillas ME, Hu MI, Jimenez C, Grubbs EG, Cote GJ. Treating Medullary Thyroid Cancer in the Age of Targeted Therapy. Int J Endocr Oncol 1(2):203-216, 2014. PMID: 25908961.
- Santarpia L, Calin GA, Adam L, Ye L, Fusco A, Giunti S, Thaller C, Paladini L, Zhang X, Jimenez C, Trimarchi F, El-Naggar AK, Gagel RF. A miRNA signature associated with human metastatic medullary thyroid carcinoma. Endocr Relat Cancer 20(6):809-23, 2013. e-Pub 2013. PMID: 24127332.
- Ayala-Ramirez M, Jasim S, Feng L, Ejaz S, Deniz F, Busaidy N, Waguespack SG, Naing A, Sircar K, Wood CG, Pagliaro L, Jimenez C, Vassilopoulou-Sellin R, Habra MA. Adrenocortical carcinoma: Clinical outcomes and prognosis of 330 patients at a tertiary care center. Eur J Endocrinol 169(6):891-9, 2013. e-Pub 2013. PMID: 24086089.
- Morris LF, Harris RS, Milton DR, Waguespack SG, Habra MA, Jimenez C, Vassilopoulou-Sellin R, Lee JE, Perrier ND, Grubbs EG. Impact and Timing of Bilateral Adrenalectomy for Refractory Adrenocorticotropic Hormone-Dependent Cushing s Syndrome. Surgery 154(6):1174-83; discussion 1183-4, 2013. PMID: 24383115.
- Thosani S, Ayala-Ramirez M, Palmer L, Hu MI, Rich T, Gagel RF, Cote G, Waguespack SG, Habra MA, Jimenez C. The Characterization of Pheochromocytoma and Its Impact on Overall Survival in Multiple Endocrine Neoplasia Type 2. J Clin Endocrinol Metab 98(11):e1813-9, 2013. e-Pub 2013. PMID: 24030942.
- Jimenez C, Rohren E, Habra MA, Rich T, Jimenez P, Ayala-Ramirez M, Baudin E. Current and Future Treatments for Malignant Pheochromocytoma and Sympathetic Paraganglioma. Curr Oncol Rep 15(4):356-71, 2013. e-Pub 2013. PMID: 23674235.
- Sridhara SK, Yener M, Hanna EY, Rich T, Jimenez C, Kupferman ME. Genetic Testing in Head and Neck Paraganglioma: Who, What, and Why?. J Neurol Surg B Skull Base 74(4):236-40, 2013. e-Pub 2013. PMID: 24436918.
- Thosani N, Thosani SN, Kumar S, Nugent Z, Jimenez C, Singh H, Guha S. Reduced Risk of Colorectal Cancer with Use of Oral Bisphosphonates: A Systematic Review and Meta-analysis. J Clin Oncol 31(5):623-30, 2013. e-Pub 2012. PMID: 23269990.
- Grubbs EG, Rich TA, Ng C, Bhosale PR, Jimenez C, Evans DB, Lee JE, Perrier ND. Long-term outcomes of surgical treatment for hereditary pheochromocytoma. J Am Coll Surg 216(2):280-9, 2013. PMID: 23317575.
- Ayala-Ramirez M, Palmer JL, Hoffman MC, de la Cruz M, Moon BS, Waguespack SG, Habra MA, Jimenez C. Bone Metastases and Skeletal-Related Events in Patients with Malignant Pheochromocytoma and Sympathetic Paraganglioma. J Clin Endocrinol Metab. e-Pub 2013. PMID: 23436918.
- Habra MA, Ejaz S, Feng L, Das P, Deniz F, Grubbs EG, Phan A, Waguespack SG, Ayala-Ramirez M, Jimenez C, Perrier ND, Lee JE, Vassilopoulou-Sellin R. A Retrospective Cohort Analysis of the Efficacy of Adjuvant Radiotherapy after Primary Surgical Resection in Patients with Adrenocortical Carcinoma. J Clin Endocrinol Metab 98(1):192-7, 2013. e-Pub 2012. PMID: 23150683.
- Carhill AA, Cabanillas ME, Jimenez C, Waguespack SG, Habra MA, Hu M, Ying A, Vassilopoulou-Sellin R, Gagel RF, Sherman SI, Busaidy NL. The Non Investigational Use of Tyrosine Kinase Inhibitors in Thyroid Cancer: Establishing a Standard for Patient Safety and Monitoring. J Clin Endocrinol Metab 98(1):31-42, 2013. e-Pub 2012. PMID: 23185034.
- Dickson PV, Alex GC, Grubbs EG, Jimenez C, Lee JE, Perrier ND. Robotic-Assisted Retroperitoneoscopic Adrenalectomy: Making a Good Procedure Even Better. Am Surg 79(1):84-9, 2013. PMID: 23317617.
- Shawa H, Deniz F, Bazerbashi H, Hernandez M, Vassilopoulou-Sellin R, Jimenez C, Habra MA. Mitotane-Induced Hyperlipidemia: A Retrospective Cohort Study. Int J Endocrinol 2013:624962, 2013. e-Pub 2013. PMID: 24348556.
- Ayala-Ramirez M, Chougnet CN, Habra MA, Palmer JL, Leboulleux S, Cabanillas ME, Caramella C, Anderson P, Al Ghuzlan A, Waguespack SG, Deandreis D, Baudin E, Jimenez C. Treatment with Sunitinib for Patients with Progressive Metastatic Pheochromocytomas and Sympathetic Paragangliomas. J Clin Endocrinol Metab 97(11):4040-50, 2012. e-Pub 2012. PMID: 22965939.
- Chuang HH, Deniz F, Sircar K, Jimenez C, Rubin De Celis C, Wood CG, Habra MA. [18F]Fluorodeoxyglucose Positron Emission Tomography-Guided Therapy in Metastatic Adrenocortical Carcinoma: An Illustrative Case. J Clin Oncol 30(26):e246-9, 2012. e-Pub 2012. PMID: 22649135.
- Morris GS, Landry CL, Grubbs EG, Jimenez C, Busaidy NL, Perrier ND. Older Patients with Primary Hyperparathyroidism have Greater than Age Predicted Functional Deficits. Endocrine Practice:1-23. e-Pub 2012. PMID: 22784831.
- Ayala-Ramirez M, Feng L, Habra MA, Rich T, Dickson PV, Perrier N, Phan A, Waguespack S, Patel S, Jimenez C. Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: Insights from the largest single-institutional experience. Cancer 118(11):2804-12, 2012. e-Pub 2011. PMID: 22006217.
- Rianon N, Alex G, Callender G, Jimenez C, Hu M, Grubbs E, Moreno M, Wathoo C, Petak S, Perrier N. Preoperative Serum Osteocalcin May Predict Postoperative Elevated Parathyroid Hormone in Patients with Primary Hyperparathyroidism. World J Surg 36(6):1320-6, 2012. e-Pub 2012. PMID: 22278606.
- Plouin PF, Fitzgerald P, Rich T, Ayala-Ramirez M, Perrier ND, Baudin E, Jimenez C. Metastatic Pheochromocytoma and Paraganglioma: Focus on Therapeutics. Horm Metab Res. e-Pub 2012. PMID: 22314389.
- Peck BW, Rich TA, Jimenez C, Kupferman ME. A Novel SDHB Mutation Associated with Hereditary Head and Neck Paraganglioma. Laryngoscope 121(12):2572-5, 2011. PMID: 22109755.
- Thosani S, Jimenez C. Opioid Induced Biochemical Alterations of the Neuroendocrine Axis. Expert Rev Endocrinol Metab 6(5):705-713, 2011. PMID: 30780884.
- Dickson PV, Alex GC, Grubbs EG, Ayala-Ramirez M, Jimenez C, Evans DB, Lee JE, Perrier ND. Posterior Retroperitoneoscopic Adrenalectomy is a Safe and Effective Alternative to Transabdominal Laparoscopic Adrenalectomy for Pheochromocytoma. Surgery 150(3):452-8, 2011. PMID: 21878230.
- Waguespack SG, Rich TA, Perrier ND, Jimenez C, Cote GJ, Medscape. Management of medullary thyroid carcinoma and MEN2 syndromes in childhood. Nat Rev Endocrinol. e-Pub 2011. PMID: 21862994.
- Varghese J, Ayala-Ramirez M, Rich T, Rohren E, Rao P, Jimenez C. Novel Germline SDHD Mutation: Diagnosis and Implications to the Patient. Fam Cancer 10(2):365-71, 2011. e-Pub 2011. PMID: 21318381.
- Khan MI, Waguespack SG, Habra MA, Broaddus R, Jimenez C. Acute-Onset Ectopic Adrenocorticotropic Hormone Syndrome Secondary to Metastatic Endometrioid Carcinoma of the Ovaries as a Fatal Complication. J Clin Oncol 29(16):e462-4, 2011. e-Pub 2011. PMID: 21422435.
- Dickson PV, Jimenez C, Chisholm GB, Kennamer DL, Ng C, Grubbs EG, Evans DB, Lee JE, Perrier ND. Posterior Retroperitoneoscopic Adrenalectomy: A Contemporary American Experience. J Am Coll Surg 212(4):659-65, 2011. PMID: 21463807.
- Ayala-Ramirez M, Feng L, Johnson MM, Ejaz S, Habra MA, Rich T, Busaidy N, Cote GJ, Perrier N, Phan A, Patel S, Waguespack S, Jimenez C. Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators. J Clin Endocrinol Metab 96(3):717-25, 2011. e-Pub 2010. PMID: 21190975.
- Ejaz S, Vassilopoulou-Sellin R, Busaidy NL, Hu MI, Waguespack SG, Jimenez C, Ying AK, Cabanillas M, Abbara M, Habra MA. Cushing Syndrome Secondary to Ectopic Adrenocorticotropic Hormone Secretion: The University of Texas MD Anderson Cancer Center Experience. Cancer. e-Pub 2011. PMID: 21412758.
- Khan MI, Habra MA, McCutcheon IE, Nogueras-González GM, Devin JK, Busaidy NL, Levine NB, Lindstrom W, Kagan D, Jimenez C, Waguespack SG. Random Postoperative Day 3 Cortisol as a Predictor of Hypothalamic-Pituitary-aAdrenal Axis Integrity After Transsphenoidal Surgery. Endocr Pract:1-25. e-Pub 2011. PMID: 21454228.
- Varghese J, Rich T, Jimenez C. Benign Familial Hypocalciuric Hypercalcemia. Endocr Pract 17 Suppl 1:13-7, 2011. PMID: 21478088.
- Jasim S, Ying AK, Waguespack SG, Rich TA, Grubbs EG, Jimenez C, Hu MI, Cote G, Habra MA. Multiple Endocrine Neoplasia Type 2B with a RET Proto-Oncogene A883F Mutation Displays a More Indolent Form of Medullary Thyroid Carcinoma Compared with a RET M918T Mutation. Thyroid 21(2):189-92, 2011. e-Pub 2010. PMID: 21186952.
- Gómez K, Varghese J, Jiménez C. Medullary Thyroid Carcinoma: Molecular Signaling Pathways and Emerging Therapies. J Thyroid Res 2011:815826, 2011. e-Pub 2011. PMID: 21687607.
- Ayala-Ramirez M, Habra MA, Busaidy N, Cote G, Rich T, Waguespack S, Jimenez C. A Catecholamine Crisis on Mount Kilimanjaro: A Hypoxia Effect?. J Travel Med 17(6):424-6, 2010. PMID: 21050326.
- Moskovic DJ, Smolarz JR, Stanley D, Jimenez C, Williams MD, Hanna EY, Kupferman ME. Malignant Head and Neck Paragangliomas: Is There an Optimal Treatment Strategy?. Head Neck Oncol 2(1):23. e-Pub 2010. PMID: 20863367.
- Morris GS, Grubbs EG, Hearon CM, Gantela S, Lee JE, Evans DB, Holmes HM, Busaidy NL, Jimenez C, Perrier ND. Parathyroidectomy Improves Functional Capacity in "Asymptomatic" Older Patients with Primary Hyperparathyroidism: A Randomized Control Trial. Ann Surg 251(5):832-7, 2010. PMID: 20395857.
- Waguespack SG, Rich T, Grubbs E, Ying AK, Perrier ND, Ayala-Ramirez M, Jimenez C. A Current Review of the Etiology, Diagnosis, and Treatment of Pediatric Pheochromocytoma and Paraganglioma. J Clin Endocrinol Metab 95(5):2023-37, 2010. e-Pub 2010. PMID: 20215394.
- Ayala-Ramirez M, Callender GG, Kupferman ME, Rich TA, Chuang HH, Trent J, Perrier ND, Goodarzi M, Jimenez C. Paraganglioma Syndrome Type 1 in a Patient with Carney-Stratakis Syndrome. Nat Rev Endocrinol 6(2):110-5, 2010. PMID: 20098451.
- Habra MA, Núñez R, Chuang H, Ayala-Ramirez M, Rich T, Kyle K, Jimenez C. Fatal Hypoglycemia in Malignant Pheochromocytoma: Direct Glucose Consumption as Suggested By (18)F-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography Imaging. Endocrine 37(1):209-12, 2010. e-Pub 2010. PMID: 20963572.
- Lodish MB, Adams KT, Huynh TT, Prodanov T, Ling A, Chen C, Shusterman S, Jimenez C, Merino M, Hughes M, Cradic KW, Milosevic D, Singh RJ, Stratakis CA, Pacak K. Succinate Dehydrogenase Gene Mutations Are Strongly Associated with Paraganglioma of the Organ of Zuckerkandl. Endocrine Related Cancer 17(3):581-8, 2010. e-Pub 2010. PMID: 20418362.
- Perrier ND, Balachandran D, Wefel JS, Jimenez C, Busaidy N, Morris GS, Dong W, Jackson E, Weaver S, Gantela S, Evans DB, Grubbs EG, Lee JE. Prospective, Randomized, Controlled Trial of Parathyroidectomy Versus Observation in Patients With "Asymptomatic" Primary Hyperparathyroidism. Surgery 146(6):1116-22, 2009. e-Pub 2009. PMID: 19879613.
- Weaver S, Doherty DB, Jimenez C, Perrier ND.. Peer-Reviewed, Evidence-Based Analysis of Vitamin D and Primary Hyperparathyroidism. World J Surg 144(6):852-8, 2009. e-Pub 2009. PMID: 19308641.
- Santarpia L, Habra MA, Jiménez C.. Malignant Pheochromocytomas and Paragangliomas: Molecular Signaling Pathways and Emerging Therapies. Horm Metab Res 41(9):680-6, 2009. e-Pub 2009. PMID: 19343618.
- Shin SH, Holmes H, Bao R, Jimenez C, Kee SS, Potylchansky E, Lee JE, Evans DB, Perrier ND. Outpatient Minimally Invasive Parathyroidectomy is Safe for Elderly Patients. J Am Coll Surg 208(6):1071-6, 2009. e-Pub 2009. PMID: 19476894.
- Stava CJ, Jimenez C, Hu MI, Vassilopoulou-Sellin R. Skeletal Sequelae of Cancer and Cancer Treatment. J Cancer Surviv 3(2):75-88. e-Pub 2009. PMID: 19412668.
- Perrier ND, Edeiken B, Nunez R, Gayed I, Jimenez C, Busaidy N, Potylchansky E, Kee S, Vu T. A Novel Nomenclature to Classify Parathyroid Adenomas. World J Surg 33(3):412-6, 2009. PMID: 19148701.
- Jimenez C, Cabanillas ME, Santarpia L, Jonasch E, Kyle KL, Lano EA, Matin SF, Nunez RF, Perrier ND, Phan A, Rich TA, Shah B, Williams MD, Waguespack SG. Use of the Tyrosine Kinase Inhibitor Sunitinib in a Patient with von Hippel-Lindau Disease: Targeting Angiogenic Factors in Pheochromocytoma and other von Hippel-Lindau Disease-related Tumors. J Clin Endocrinol Metab 94(2):386-91, 2009. e-Pub 2008. PMID: 19017755.
- Jaishuen A, Jimenez C, Sirisabya N, Li Y, Zheng H, Hu W, Urbauer DL, Kavanagh JJ. Poor Survival Outcome With Moderate and Severe Hypercalcemia in Gynecologic Malignancy Patients. Int J Gynecological Cancer 19(2):178-85, 2009. PMID: 19395991.
- Habra MA*, Jimenez C*(*Co-First Authors), Huang SC, Cote GJ, Murphy WA, Gagel RF, Hoff AO. Expression Analysis of Fibroblast Growth Factor-23, Matrix Extracellular Phospho Glycoprotein, Secreted Frizzled-Related Protein-4, and Fibroblast Growth Factor-7: Identification of Fibroblast growth factor-23 and Matrix Extracellular Phospho Glycoprotein as Major Factors Involved in Tumor-Induced Osteomalacia. Endocrine Practice 14(9):1108-14, 2008. PMID: 19158050.
- Grubbs EG, Rafeeq S, Jimenez C, Feng L, Lee JE, Evans DB, Perrier ND. Preoperative Vitamin D Replacement Therapy in Primary Hyperparathyroidism: Safe and Beneficial?. Surgery 144(6):852-8; discussion 858-9, 2008. PMID: 19040987.
- Jimenez C, Burman P, Abs R, Clemmons DR, Drake WM, Hutson KR, Messig M, Thorner MO, Trainer PJ, Gagel RF. Follow-up of Pituitary Tumor Volume in Patients With Acromegaly Treated with Pegvisomant in Clinical Trials. Eur J Endocrinol 159(5):517-23, 2008. e-Pub 2008. PMID: 18708436.
- Perrier ND, Kennamer DL, Bao R, Jimenez C, Grubbs EG, Lee JE, Evans DB. Posterior Retroperitoneoscopic Adrenalectomy: Preferred Technique for Removal of Benign Tumors and Isolated Metastases. Ann Surg 248(4):666-74, 2008. PMID: 18936580.
- Rich TA, Jonasch E, Matin S, Waguespack SG, Gombos DS, Santarpia L, Stolle C, Jimenez C. A Novel Von Hippel-Lindau Point Mutation Presents As Apparently Sporadic Pheochromocytoma. Cancer Invest 26(6):642-6, 2008. PMID: 18584357.
- Jiménez C, Hu MI, Gagel RF. Management of Medullary Thyroid Carcinoma. Endocrinol Metab Clin North Am 37(2):481-96, 2008. PMID: 18502338.
- Hu MI, Gagel RF, Jimenez C. Bone Loss in Patients With Breast or Prostate Cancer. Curr Osteoporos Rep 5(4):170-8, 2007. PMID: 18430392.
- Stava CJ, Jimenez C, Vassilopoulou-Sellin R. Endocrine Sequelae of Cancer and Cancer Treatments. J Cancer Surviv 1(4):261-74. e-Pub 2007. PMID: 18648961.
- Jimenez C, Yang Y, Kim HW, Al-Sagier F, Berry DA, El-Naggar AK, Patel S, Vassilopoulou-Sellin R, Gagel RF. Primary Hyperparathyroidism and Osteosarcoma: Examination of a Large Cohort Identifies Three Cases of Fibroblastic Osteosarcoma. J Bone Miner Res 20(9):1562-8, 2005. e-Pub 2005. PMID: 16059628.
- Jimenez C, Moran SA, Sereti I, Wynne S, Yen PM, Falloon J, Davey RT, Sarlis NJ. Graves Disease After Interleukin-2 Therapy in a Patient With Human Immunodeficiency Virus Infection. Thyroid 14(12):1097-102, 2004. PMID: 15650365.
- Busaidy NL*, Jimenez C*(*Co-First Authors) Habra MA, Schultz PN, El-Naggar AK, Clayman GL, Asper JA, Diaz EM, Evans DB, Gagel RF, Garden A, Hoff AO, Lee JE, Morrison WH, Rosenthal DI, Sherman SI, Sturgis EM, Waguespack SG, Weber RS, Wirfel K, Vassilopoulou-Sellin R. Parathyroid Carcinoma: A 22-year Experience. Head and Neck 26(8):716-26, 2004. PMID: 15287039.
- Jimenez C, Habra MA, Huang SC, El-Naggar A, Shapiro SE, Evans DB, Cote G, Gagel RF. Pheochromocytoma and Medullary Thyroid Carcinoma: A New Genotype-Phenotype Correlation of the RET Protooncogene 891 Germline Mutation. J Clin Endocrinol Metab 89(8):4142-5, 2004. PMID: 15292360.
- Jimenez C, Gagel RF. Genetic Testing in Endocrinology: Lessons Learned from Experience With Multiple Endocrine Neoplasia Type 2 (MEN2). Growth Hormone IGF Res 14 Suppl A:S150-7, 2004. PMID: 15135800.
- Jimenez C, Dang GT, Schultz PN, El-Naggar A, Shapiro S, Barnes EA, Evans DB, Vassilopoulou-Sellin R, Gagel RF, Cote GJ, Hoff AO. A Novel Point Mutation of the RET Proto-Oncogene Involving the Second Intracellular Tyrosine Kinase Domain in a Family with Medullary Thyroid Carcinoma. J Clin Endocrinol Metab 7(7):3521-26, 2004. PMID: 15240641.
Other Articles
- Pabón N, Garavito G, Jimenez C Adrenocortical Carcinoma: Comments from the Adrenocortical Cancer Consensus. Revista Colombiana de Cancerología Vol. 10, No. 2, 2006.
- Jimenez C, Cadena E, de Francisco J, Guevara G, Garavito G Multiple Endocrine Neoplasia Type 2: A Model for Cancer Prevention. Revista Colombiana de Cancerología Vol. 9, No 2:23-27, 2005.
- Jimenez C, Garavito G Seminars in Oncologic Emergencies: Humoral Hypercalcemia of Malignancy. Revista Colombiana de Cancerología Vol. 9, No. 2:30-35, 2005.
- Builes C, De Francisco J, Garavito G, Jimenez C Parathyroid Carcinoma, Preoperative preparation with Bisphosphonates prevents severe Hungry Bone Syndrome. Revista de la Asociación Colombiana de Osteoporosis y Metabolismo Mineral, 2005.
- Jimenez C Bone Plasticity. Editorial Revista de la Asociación Colombiana de Osteoporosis y Metabolismo Mineral, 2005.
Abstracts
- Walter T, Gong K, Nakamura E, Iliopoulos O, Jimenez C, Capdevila J, Liu P, Jin F, Naik GS, Jonasch E. LITESPARK-015 Cohort B1: A Phase 2 Open-Label Study of Belzutifan (An HIF-2α Inhibitor) Monotherapy in Patients With von Hippel-Lindau (VHL) Disease–Associated Tumors, 2023.
- Jimenez C. A Phase 2 Open-Label Study of Belzutifan (a HIF-2α Inhibitor) Monotherapy in Patients with Advanced/Metastatic Pheochromocytoma/Paraganglioma or Pancreatic Neuroendocrine Tumors, 2022.
- Jimenez C. Multidisciplinary Perspectives on High-Specific-Activity I-131 MIBG in Advanced Pheochromocytoma and Paraganglioma (PPGL), 2022.
- Wu J, Lakomy DS, Fellman BM, Salcedo MP, Sood, AK, Jhingran A, Klopp AH, Iyer RB, Jimenez C, Colbert LE, Schmeler KM, Eifel PJ, Lin LL. Bone mineral density of in-field and out-of-field lumbar vertebrae in cervical cancer patients. ASTRO, 2021.
- Jimenez C, Chin BB, Noto RB, Dillon JS, Solnes L, DiPippo V, Stambler N, Wong V, Pryma DA. Updated Long-term Survival and Safety from a Multi-Center, Open-Label, Pivotal Phase 2 Study of AZEDRA&[reg] in Patients with Unresectable, Locally Advanced or Metastatic Pheochromocytoma or Paraganglioma. The Journal of Urology, 2020. e-Pub 2020.
- Jimenez C, Chin BB, Noto RB, Dillon JS, Solnes LB, DiPippo VA, Stambler N, Wong V, Pryma DA. A Multi-Center, Open-Label, Pivotal Phase 2 Study of Azedra® (HSA I-131-MIBG) in Patients with Unresectable, Locally Advanced or Metastatic Pheochromocytoma or Paraganglioma: Updated Long-Term Survival and Safety, 2020.
- Campbell M, XieW, Shah A, Habra MA, Jimenez C, Venkatesan A, Killbridge K, Bubley G, Mortazavi A, Bilen M, McKay R, Choueiri T, McGregor B. Initial Results of a Phase II study of Nivolumab and Ipilimumab in Metastatic Adrenal Tumors. Annals of Oncology, 2019.
- Dickson PV, Alex GC, Grubbs EG, Jimenez C, Lee JE, Perrier ND. Robotic Retroperitoneoscopic Adrenalectomy: Making a Good Procedure Even Better. ACS 97th Annual Clinical Congress, San Francisco, CA, 2011.
- Alex G, Rianon N, Callender G, Moreno M, Jimenez C, Hu M, Grubbs E, Lee J, Perrier N. Preoperative Serum Osteocalcin May Predict Postoperative Elevated Parathyroid Hormone in Patients with Primary Hyperparathyroidism. International Association of Endocrine Surgeons (IAES), Yokohama, Japan, 2011.
- Vu T, Warneke C, Grubbs L, Jimenez C, Perrier N. Vitamin D Supplementation Does Not Alter Size or Perfusion of Parathyroid Adenomas. International Association of Endocrine Surgery (IAES), Yokohama, Japan, 2011.
- Alford EM, Murphy WA, Shah J, Jimenez C, Lee B, Hu M. An Unusual Case of Acquired and Rapid Osteosclerosis. ENDO 2011, Boston, MA, 2011.
- Ayala-Ramirez M, Habra M, Busaidy N, Perrier N, Rich T, Waguespack S, Phan A, Patel S, Jimenez C. Clinical Benefits of Chemotherapy in Patients with Metastatic Pheochromocytomas and Sympathetic Paragangliomas: Review of the Largest Single-Institution Experience. ENDO 2011, Boston, MA, 2011.
- Ayala-Ramirez M, Habra M, Rich T, Cote G, Busaidy N, Anderson P, Waguespack S, Phan A, Patel S, Jimenez C. Experience with the Tyrosine Kinase Inhibitor Sunitinib in Metastatic Pheochromocytomas and Paragangliomas. ENDO 2011, Boston, MA, 2011.
- Varghese J, Ayala-Ramirez M, Vaporciyan A, Liao Z, Habra M, Jimenez C. Mediastinal Paragnaglioma: The University of Texas MD Anderson Cancer Center (MDACC) Experience. ENDO 2011, Boston, MA, 2011.
- Pryma DA, Barrett JA, Coleman RE, Noto R, Jimenez C, Pampaloni MH, Serafini AN, Wahl RL, Kostakoglu L, LaFrance ND, Babich JW. Preliminary Data from an Ongoing Phase 2b Study of No Carrier Added 131 I-iobenguane (nca-MIBG) in Patients with Maligant Pheochromocytoma (Pheo). 2011 ASCO Annual Meeting, Chicago, IL, 2011.
- Dickson PV, Jimenez C, Chisholm GB, Kennamer DL, Ng C, Grubbs EG, Evans DB, Lee JE, Perrier ND. Posterior Retroperitoneoscopic Adrenalectomy: A Contemporary American Experience (Shiply Award Winner). Southern Surgical Association, 2010.
- Schmeler KM, Jhingran A, Iyer RB, Munsell M, Kim E, Jimenez C, Sun CC, Moore CL, Kitaka S, Eifel PJ, Klopp AH, Sood AK. Significant Decreases in Bone Mineral Density Associated with Pelvic Radiotherapy: A Prospective Logitudinal Study of Women with Gynecologic Malignancies. 13th Biennial Meeting of the International Gynecological Cancer Society (IGCS 2010), Prague, 2010.
- Ying AK, Jasim S, Waguespack SG, Rich TA, Grubbs EG, Jimenez C, Cote G, Habra MA. Multiple Endocrine Neoplasia Type 2b with A ret Proto-Oncogene A883F Mutation Displays a More Indolent form of Medullary Thyroid Carcinoma Compared with RET M918T Mutation. MEN 2010 12th International Workshop on Multiple Endocrine Neoplasia, Gubbio, Italy, 2010.
- Michaelis CL, Cote GJ, Santarpia L, Klein MJ, Gornet TG, Fritsche HA, Busaidy NL, Waguespack SG, Cabanillas ME, Hu MI, Jimenez C, Sherman SI. Detection of Circulating Tumor Cells (CTCs) in Patients with Thyroid Cancer. The Endocrine Society's 92nd Annual Meeting and Expo, San Diego, CA, 2010.
- Busaidy NL, Vu T, Grubbs E, Urbauer D, Kim E, Landry C, Jimenez C, Hu MI, Waguespack SG, Gomez H, Perrier ND. 4D Neck CT Versus SPECT/CT Using Tc99m Sestamibi in the Localization of Parathyroid Adenomas: Which Study and When?. The Endocrine Society's 92nd Annual Meeting and Expo, San Diego, CA, 2010.
- Khan MI, McCutcheon IE, Nogueras-Gonzalez GM, Devin JK, Jimenez C, Habra MA, Levine NB, Waguespack SG. Post-Operative Day 3 Cortisol as a Predictor of HPA Axis Integrity after Transsphenoidal Surgery. The Endocrine Society's 92nd Annual Meeting and Expo, San Diego, CA, 2010.
- Ayala-Ramirez M, Hernandez M, Habra MA, Busaidy NL, Cote G, Rich TA, Waguespack SG, Jimenez C. Survival Rates in Patients with Metastatic Pheochromocytomas and Paragangliomas. The Endocrine Society's 92nd Annual Meeting and Expo, San Diego, CA, 2010.
- Ejaz S, Waguespack SG, Sellin RV, Busaidy NL, Jimenez C, Ying AK, Hu MI, Cabanillas ME, Gagel RF, Habra MA. ACTH-Dependent Ectopic Cushing's Syndrome: The University of Texas M.D. Anderson Cancer Center Experience. The Endocrine Society's 92nd Annual Meeting and Expo, San Diego, CA, 2010.
- Ayala-Ramirez M, Habra MA, Busaidy NL, Cote G, Rich TA, Waguespack SG, Jimenez C. A Catecholamine Crisis on Mount Kilimanjaro: A Hypoxia Effect?. The Endocrine Society's 92nd Annual Meeting and Expo, San Diego, CA, 2010.
- Barrera T, Rich TA, Perrier ND, McCutcheon IE, Jimenez C, Habra MA. Pheochromocytoma and Cushing's Disease: A Rare Combination with Unclear Etiology. The Endocrine Society's 92nd Annual Meeting and Expo, San Diego, CA, 2010.
- Westin JR, Thompson MA, Cataldo VD, Toth BB, Sanjorjo P, Bourgeois S, Jimenez C, Murphy WA, Kwak LW, Hagemeister FB. The Effect of Zoledronic Acid on the Prevention of Bone Loss in Lymphoma Patients Receiving First-line Therapy, 2010.
- Westin JR, Thompson MA, Cataldo VD, Toth BB, Sanjorjo P, Bourgeois S, Jimenez C, Murphy W, Fanale M, Fayad L, Fowler N, Kwak L, McLaughlin P, Neelapu S, Pro B, Rodriguez A, Shah J, Hagemeister FB. Bone Loss in Lymphoma Patients Prior to Receiving Front-Line Therapy. Clinical Lymphoma, Myeloma & Leukemia 20(3 / June 2010):E32, 2010.
- Lodish MB, Adams K, Huynh TT, Prodanov T, Ling A, Jimenez C, Stratakis CA, Pacak K. Succinate Dehydrogenase Mutations Are Strongly Associated With Paraganglioma of the Organ of Zuckerkandl in Pediatric and Adult Patients. 8th European Society of Pediatric Endocrinology, 2009.
- V.D. Cataldo, M.A. Thompson, B.B. Toth, P. Sanjorjo, S. Bourgeois, B.N. Bekele, C. Jimenez, W.A. Murphy, A.O. Huen, S.A. Byfield, F.B. Hagemeister. Zoledronic Acid for the Prevention of Bone Loss in Patients with Previously Untreated Lymphoma Undergoing Chemotherapy. ASCO, Orlando, 2009, 2009.
- Guthikonda A, Jimenez C. Thyroid Leukemia. AACE, Houston, 2009, 2009.
- Callender GG, Moreno M, Jimenez C, Hu MI, Grubbs EG,. Osteocalcin: Preoperative Predictor of Bone Hunger after Parathyroidectomy. AACE, Houston 2009, 2009.
- Cabanillas M, Nunez R, Williams M, Jimenez C. Suture Granulomas Represent a False Positive MIBG Result, 2nd International Symposium on Pheochromocytoma. Queens College Cambridge, UK, Sept 2008, 2008.
- Jimenez C, Clemmons DR, Drake WM, Hutson KR, Thorner MO, Trainer PJ, Gagel RF. Long-Term Follow-up of Pituitary Tumor Volume in Patients with Acromegaly treated with Pegvisomant. ENDO 2005, 2005.
- Jimenez C, Habra A, Busaidy N, Vasudevan A, Gagel RF, Sarlis, NJ. Capecitabine and Radiotherapy Induce Disease Stabilization in a Case of Poorly Differentiated Follicular Thyroid Carcinoma, 2004.
- Busaidy NL, Hymes SR, Jimenez C, Habra MA, Sarlis NJ. Progression of Medullary Thyroid Carcinoma Manifested as Skin Metastasis with Inflammatory Features, 2004.
- Busaidy N, Habra MA, Jimenez C, Gagel RF. Diabetes Mellitus: A Possible Paraneoplastic Syndrome?, 2004.
- Jimenez C, Habra MA, Huang SC, El-Naggar A, Shapiro SE, Evans DB, Cote G, Gagel RF. Pheochromocytoma and Medullary Thyroid Carcinoma: A New Genotype-Phenotype Correlation of the RET Proto-Oncogene 891 Germline Mutation. J Clin Endocrinol Metab 89(8):4142-5, 2004. PMID: 15292360.
- Jimenez C, Habra MA, Busaidy N, Vasudevan A, Gagel RF, Sarlis NJ. Portal Hypertension: Another Complication of Metastatic Medullary Thyroid Carcinoma, 2004.
- Busaidy N, Jimenez C, Habra MA, Gagel RF. Secondary or Tertiary Hyperparathyroidism in Tumor Induced Osteomalacia, 2004.
- Asper JA, Rosenthal DI, Garden AS, Clayman G, Jimenez C, Ang KK. Parathyroid Carcinoma: The Role of Postoperative Radiation Therapy (Oral Presentation), 2004.
- Habra MA, Jimenez C, Busaidy N, Vassilopoulou-Sellin R. Hyperprolactinemia as Initial Manifestation of Cowden Syndrome, 2004.
- Jimenez C, Burman P, Clemmons D, Drake W, Thorner M, Trainer P, Gagel RF. Long-term follow-up of Pituitary Tumor Volume in Patients with Acromegaly Treated with Pegvisomant, 2004.
- Garavito G, Neira F, Mejia C, Restrepo L, Penagos P, Yeung, SCJ, Jimenez C. A Woman with Acromegaly, a Normal Pituitary, and a Parasellar Mass. Where is the Excessive Growth Hormone Secretion Coming From?, 2003.
- Jimenez C, Kim HW, Al-Sagier F, El-Naggar A, Sellin R, Berry D, Gagel RF. Primary Hyperparathyroidism and Osteosarcoma: Examination of a Large Cohort Identifies Unique Characteristics (Oral Presentation), 2003.
- Jimenez C, Maple S, Gagel R,. Bone Mineral Density in Patients with Acromegaly under Therapy with Pegvisomant. ENDO, Philadelphia 2002, 2003.
- Jimenez C, Maple S, Al-Sghir F, Gagel R. Lack of Further Growth in the Size of 2 Pituitary Growth Hormone Producing Tumors After Initiation of Pegvisomant Therapy, 2003.
- Jimenez C, Maple S, Schultz P, Gagel R. Treatment of Acromegaly with Pegvisomant, a Growth Hormone Receptor Antagonist, Does Not Reduce Bone Mass, 2003.
- Busaidy N, Jimenez C, Habra M, Schultz P, El-Naggar A, Clayman G, Vassilopoulou-Sellin R. Parathyroid Carcinoma, The University of Texas M. D. Anderson Cancer Center Experience, 2003.
- Jimenez C, Habra M, Busaidy N, Wirfel K, El-Naggar A, Vassilopoulou-Sellin R. Parathyroid Carcinoma, MD Anderson Cancer Center Experience. Head and Neck Surgery Journal, 2003.
- Roman F, Bentancourt M, Case C, Jimenez C,Wirfel K. Non-Islet Cell Tumor Hypoglycemia: Case presentation, Hormonal Evaluation and Options for Palliative Treatment, 2002.
- Levis S, Gomez A, Jimenez C, Vera L, Hollis BW, Lai S, Roos B. Decreased Seasonal Variation in Vitamin D Levels in Medical Outpatients in Miami, Florida (Unites States). ENDO Denver, CO, 2003, 2001.
- Gomez A, Veras L, Jimenez C, Hollis BW, Lai S, Roos B, Lewis S. Diminished Seasonal Vitamin D and PTH Changes in South Florida. Geriatrics, Chicago, IL,, 2001.
- Levis S, Gomez A, Jimenez C, Veras L, Hollis BW, Lai S, Roos B. Sustained 25(OH) Vitamin D Levels Throughout the Year in the Elderly Population of South Florida. ECTS, Madrid, Spain May 2001, 2000.
Book Chapters
- Jimenez C, Armaiz-Pena G, Dahia PLM, Lu Y, Toledo RA, Varghese J, Habra MA. Endocrine and Neuroendocrine Tumors Special Issue—Checkpoint Inhibitors for Adrenocortical Carcinoma and Metastatic Pheochromocytoma and Paraganglioma: Do They Work?. In: Endocrine and Neuroendocrine Cancers. Cancers: Switzerland, 159-176, 2023.
- Jimenez C, Gagel RF,. Disorders Affecting Multiple Endocrine Systems. In: Harrison's Principles of Internal Medicine. 18th. McGraw Hill, 2011.
- Silberfein E, Jimenez C, Perrier N. Pheochromocytomas. In: Cameron, 2010.
- Rich TA, Jimenez C, Evans DB. Hereditary Pheochromocytoma and Multiple Endocrine Neoplasia Type 2 (MEN2). In: Genetic Diagnosis of Endocrine Disorders, 2010.
- Jimenez C, Gagel RF. Multiple Endocrine Neoplasia. In: Harrison's Hematology and Oncology. McGraw-Hill, 597-608, 2010.
- Jimenez C, Gagel RF. Multiple Endocrine Neoplasias and Autoimmune Endocrinopathies. In: Harrison's Endocrinology. Second. McGraww-Hill, 367-378, 2010.
- Jimenez C. Neuroendocrinology. In: Neurology. 2. Manual Moderno: Mexico, 391-403, 2010.
- Jimenez C, Gagel R. Disorders Affecting Multiple Endocrine Systems. In: Harrison's Principles of Internal Medicine. 17th. McGraw Hill, 2008.
- Rich T, Jimenez C, Evans D. Genetic Evaluation of Pheochromocytomas. Genetic Diagnosis of Endocrine Disorders. In: Endocrine Neoplasms, 2008.
- Jimenez C. Thyroid Cancer. In: Medicina Interna (Internal Medicine). First. Colombian Association of Internal Medicine, 2006.
- Jimenez C, Garavito G, Ramos P. Neuroendocrine Tumors of the Gastrointestinal Tract. In: Gastroenterología. Second, 2005.
Grant & Contract Support
| Title: | Phase 4 Azedra Trial: An Observational Study to Assess the Risk of Secondary Malignancies Following Treatment with AZEDRA® |
| Funding Source: | Latheus |
| Role: | Principal Investigator |
| Title: | A Phase 2 Study to Evaluate the Efficacy and Safety of Belzutifan (MK-6482, formerly PT2977) Monotherapy in Participants with Advanced Pheochromocytoma/Paraganglioma (PPGL) or Pancreatic Neuroendocrine Tumor (pNET) |
| Funding Source: | Merck & Co., Inc |
| Role: | Principal Investigator |
Patient Reviews
CV information above last modified August 21, 2024